Continuous Glucose Monitoring Market Will Grow at 14.8% CAGR Till 2020

PORTLAND, Oregon, April 24, 2014 /PRNewswire/ --

The database of Research Beam has a latest addition of report, titled "Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 -2020." This report prepared with insightful analysis provides a microscopic view about continuous glucose monitoring market to healthcare industry professionals. This extensively studied report is fully versed with business insights and opportunistic ideas.

To browse the full report, visit us @ http://www.researchbeam.com/continuous-glucose-monitoring-cgm-market

In 2012, the report observed the value of CGM to be $194.8 million. However, factors such as rising awareness about CGM's, earlier detection of hyperglycemic and hypo condition, affectivity over conventional devices would take global CGM market to $568.5 million by 2020 with a CAGR of 14.8%.

"The market is overcoming several challenges towards the commercialization of closed loop CGMs with significant focus on technological innovation. This is expected to take the concept of CGM to a next level from research to mass adoption," noted by analyst. Despite such encouraging innovations, commercialization has not reached to desired levels. Major factors responsible for this are issues related with accuracy as well as cost, less attractive reimbursement coverage, and strict regulatory impositions. "However, the under commercialization is presenting opportunities for the marketers as new and innovative products will easily take the advantage of lower product presence," Debbie explains. The impact of FDA approval for artificial pancreas, superiority of CGMs over self-monitoring devices and rise in diabetes cases will have significant impact on the overall market growth.

Similar market research reports at Research Beam: 

Global Cardiovascular Surgical Devices and Technologies Market:

Cardiovascular surgery is the process performed to cure the heart tissue defects such as replacing the diseased heart valves if it is blocked, grafting or replacement of heart tissues in case of damage. There are two major types of heart surgeries performed, namely closed and open types of surgeries. The global surgical device market is the parent market for cardiovascular devices, which was valued at $240 billion in 2013. Increase in incidence for heart related problems are mainly due to changes in life style. This life style changes has increased the rate of heart surgeries. The U.S. is the leading market for cardiovascular surgical devices due to increase in aging population that is suffering from cardiovascular problems.

View the Global Cardiovascular Surgical Devices and Technologies Market report@

 http://www.researchbeam.com/cardiovascular-surgical-devices-and-technologies-market

Plastic Processing Machinery Markets in China:

China's demand for Plastic Processing Machinery has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.

View the Plastic Processing Machinery Markets in China market research report @ http://www.researchbeam.com/china-plastic-processing-machinery-market

Chinese guidebook for Medical Device Adverse Event Reporting and Monitoring Regulations (2014 Edition):

China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion. On the Chinese healthcare market, imported drugs made by overseas and multinational pharmaceutical manufacturers account for about one fourth. It is estimated that total value of drugs on Chinese healthcare market will be likely to be more than 1450 billion RMB by 2015, and will surpass Japan to become the second largest drug market following the United States. The Chinese healthcare market will attract more and more overseas pharmaceutical manufacturers and producers to penetrate such market. 

View the Chinese guidebook for Medical Device Adverse Event Reporting and Monitoring Regulations report @ http://www.researchbeam.com/chinese-guidebook-for-medical-device-adverse-event-reporting-and-monitoring-regulations-market

Global Wearable Medical Devices (Home Healthcare) Market:

Wearable medical devices are handheld monitoring tools used in identification and monitoring of disease. Due to the Increase in chronic diseases, patients are opting home healthcare as a cost effective and efficient way of treatment, rather than hospital services. Medical device market accounted for $240 billion in 2013. However, increase in incidence of chronic diseases restricts the growth of wearable medical device market. Neurological diseases in people have increased to 7.2% in urban areas, causing hurdles for monitoring through wearable medical devices.

View the Global Wearable Medical Devices (Home Healthcare) Market report @

http://www.researchbeam.com/wearable-medical-devices-market

Providing minutest details of every sector, this report divides Global CFM market on the basis of age, devices, types of diabetes and application. A deep dive study by AMR revealed the home settings market to lead the CGM application market in terms of revenue. However, the application of GCM under application market would attract plethora of investors between 2013 and 2020.

Study by AMR suggests that the receivers and transmitters attained highest revenue in overall Global continuous glucose monitoring systems market with a value of $88.5 million in 2012. However, during the analysis period, more improvements can be witnessed in glucose sensors and hence, the report rightfully suggest that the glucose sensors would generate the highest revenue during 2013 to 2020.

The report also provides a holistic views about geographies that play a vital role in Global continuous glucose monitoring systems market. As per the latest findings by AMR, North America has the highest growth in terms of revenue. Further, Asia Pacific is expected to achieve highest growth rate during the forecast period.

To view all market research reports of this publisher, visit us @ http://www.researchbeam.com/allied-market-research-publisher

This report gives you detailed insights about various companies involved in CGM markets. The companies are listed below

• Medtronic Inc.,
• Dexcom Inc.,
• Novo Nordisk,
• Spring Health Solution Ltd,
• Roche, Animas Corporation,
• Ypsomed AG,
• Insulet Corporation

About Us: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities.

In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports from our clients.

We have business relations with numerous clients of different verticals. Hence, we bring to you market research reports of various fields and carter to number of organizations. This is the spot on place for all your market research needs.

We are home to a very proactive and energetic team who strives to solve user queries as soon as possible. They will also help you to know about latest market trends and practices.

Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact:

Sona Padman
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
United States
Direct: +1(617)674-4143
Toll Free: +1(855)711-1555 (U.S. & Canada)
Fax: +1(855)550-5975
Email: sales@researchbeam.com